Stocks and Investing Stocks and Investing
Fri, September 20, 2024
Thu, September 19, 2024

Adam Maeder Initiated (ABT) at Buy and Held Target at $131 on, Sep 19th, 2024


Published on 2024-10-28 14:21:25 - WOPRAI, Adam Maeder
  Print publication without navigation


Adam Maeder of Piper Sandler, Initiated "Abbott Laboratories" (ABT) at Buy and Held Target at $131 on, Sep 19th, 2024.

Adam has made no other calls on ABT in the last 4 months.



There are 6 other peers that have a rating on ABT. Out of the 6 peers that are also analyzing ABT, 0 agree with Adam's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Adam


  • Raj Denhoy of "Jefferies" Maintained at Strong Buy with Increased Target to $120 on, Tuesday, August 27th, 2024
  • Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Increased Target to $127 on, Thursday, August 22nd, 2024
  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $143 on, Monday, July 29th, 2024
  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Decreased Target to $120 on, Tuesday, July 2nd, 2024
  • Shagun Singh of "RBC Capital" Reiterated at Buy and Held Target at $125 on, Tuesday, June 4th, 2024
  • David Roman of "Goldman Sachs" Initiated at Strong Buy and Held Target at $121 on, Thursday, May 30th, 2024
Contributing Sources